annual current liabilities:
$1.19B+$218.49M(+22.58%)Summary
- As of today (May 29, 2025), ALNY annual total current liabilities is $1.19 billion, with the most recent change of +$218.49 million (+22.58%) on December 31, 2024.
- During the last 3 years, ALNY annual current liabilities has risen by +$490.56 million (+70.51%).
- ALNY annual current liabilities is now at all-time high.
Performance
ALNY Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$1.08B-$110.65M(-9.33%)Summary
- As of today (May 29, 2025), ALNY quarterly total current liabilities is $1.08 billion, with the most recent change of -$110.65 million (-9.33%) on March 31, 2025.
- Over the past year, ALNY quarterly current liabilities has increased by +$133.91 million (+14.22%).
- ALNY quarterly current liabilities is now -11.88% below its all-time high of $1.22 billion, reached on September 30, 2024.
Performance
ALNY quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ALNY Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.6% | +14.2% |
| 3 y3 years | +70.5% | +77.5% |
| 5 y5 years | +236.4% | +217.5% |
ALNY Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +70.5% | -11.9% | +77.5% |
| 5 y | 5-year | at high | +236.4% | -11.9% | +217.5% |
| alltime | all time | at high | >+9999.0% | -11.9% | >+9999.0% |
ALNY Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.08B(-9.3%) |
| Dec 2024 | $1.19B(+22.6%) | $1.19B(-2.8%) |
| Sep 2024 | - | $1.22B(+15.7%) |
| Jun 2024 | - | $1.06B(+12.1%) |
| Mar 2024 | - | $941.71M(-2.7%) |
| Dec 2023 | $967.79M(+26.0%) | $967.79M(+1.9%) |
| Sep 2023 | - | $949.78M(+20.4%) |
| Jun 2023 | - | $788.64M(+17.1%) |
| Mar 2023 | - | $673.39M(-12.3%) |
| Dec 2022 | $767.91M(+10.4%) | $767.91M(-0.6%) |
| Sep 2022 | - | $772.79M(+17.5%) |
| Jun 2022 | - | $657.68M(+8.5%) |
| Mar 2022 | - | $605.96M(-12.9%) |
| Dec 2021 | $695.71M(+18.9%) | $695.71M(+13.9%) |
| Sep 2021 | - | $610.66M(+10.1%) |
| Jun 2021 | - | $554.65M(+12.1%) |
| Mar 2021 | - | $494.82M(-15.5%) |
| Dec 2020 | $585.27M(+66.0%) | $585.27M(+21.9%) |
| Sep 2020 | - | $480.24M(+25.0%) |
| Jun 2020 | - | $384.30M(+13.4%) |
| Mar 2020 | - | $338.79M(-3.9%) |
| Dec 2019 | $352.59M(+96.4%) | $352.59M(-0.1%) |
| Sep 2019 | - | $352.86M(+7.4%) |
| Jun 2019 | - | $328.60M(+120.3%) |
| Mar 2019 | - | $149.16M(-16.9%) |
| Dec 2018 | $179.49M(+24.4%) | $179.49M(+47.7%) |
| Sep 2018 | - | $121.50M(+6.9%) |
| Jun 2018 | - | $113.66M(-1.5%) |
| Mar 2018 | - | $115.38M(-20.0%) |
| Dec 2017 | $144.25M(+9.5%) | $144.25M(+42.8%) |
| Sep 2017 | - | $101.05M(-7.1%) |
| Jun 2017 | - | $108.73M(+13.5%) |
| Mar 2017 | - | $95.79M(-27.3%) |
| Dec 2016 | $131.70M(+112.1%) | $131.70M(+61.1%) |
| Sep 2016 | - | $81.76M(+15.8%) |
| Jun 2016 | - | $70.58M(+6.3%) |
| Mar 2016 | - | $66.37M(+6.9%) |
| Dec 2015 | $62.10M(-34.9%) | $62.10M(+8.7%) |
| Sep 2015 | - | $57.11M(-14.2%) |
| Jun 2015 | - | $66.60M(-17.5%) |
| Mar 2015 | - | $80.69M(-15.4%) |
| Dec 2014 | $95.33M | $95.33M(+67.7%) |
| Sep 2014 | - | $56.85M(+5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $53.74M(-35.9%) |
| Mar 2014 | - | $83.83M(+55.6%) |
| Dec 2013 | $53.86M(+11.4%) | $53.86M(-1.9%) |
| Sep 2013 | - | $54.90M(+3.4%) |
| Jun 2013 | - | $53.07M(+6.7%) |
| Mar 2013 | - | $49.75M(+2.9%) |
| Dec 2012 | $48.34M(-40.3%) | $48.34M(-11.7%) |
| Sep 2012 | - | $54.76M(-4.0%) |
| Jun 2012 | - | $57.06M(-14.4%) |
| Mar 2012 | - | $66.64M(-17.7%) |
| Dec 2011 | $80.99M(-20.6%) | $80.99M(-13.8%) |
| Sep 2011 | - | $93.93M(-6.6%) |
| Jun 2011 | - | $100.53M(+1.2%) |
| Mar 2011 | - | $99.34M(-2.6%) |
| Dec 2010 | $102.05M(-7.8%) | $102.05M(+2.6%) |
| Sep 2010 | - | $99.43M(-2.5%) |
| Jun 2010 | - | $102.03M(+3.5%) |
| Mar 2010 | - | $98.57M(-11.0%) |
| Dec 2009 | $110.73M(+11.3%) | $110.73M(+9.5%) |
| Sep 2009 | - | $101.12M(-1.2%) |
| Jun 2009 | - | $102.33M(-1.8%) |
| Mar 2009 | - | $104.25M(+4.8%) |
| Dec 2008 | $99.45M(+19.1%) | $99.45M(-2.5%) |
| Sep 2008 | - | $102.02M(-3.5%) |
| Jun 2008 | - | $105.73M(+24.5%) |
| Mar 2008 | - | $84.91M(+1.7%) |
| Dec 2007 | $83.48M(+264.1%) | $83.48M(-4.5%) |
| Sep 2007 | - | $87.46M(+222.6%) |
| Jun 2007 | - | $27.11M(+15.4%) |
| Mar 2007 | - | $23.50M(+2.5%) |
| Dec 2006 | $22.93M(+24.0%) | $22.93M(+6.5%) |
| Sep 2006 | - | $21.53M(+4.5%) |
| Jun 2006 | - | $20.60M(+3.1%) |
| Mar 2006 | - | $19.99M(+8.1%) |
| Dec 2005 | $18.48M(+181.1%) | $18.48M(+131.0%) |
| Sep 2005 | - | $8.00M(-11.3%) |
| Jun 2005 | - | $9.02M(+47.0%) |
| Mar 2005 | - | $6.14M(-6.6%) |
| Dec 2004 | $6.58M(+71.0%) | $6.58M(-1.0%) |
| Sep 2004 | - | $6.64M(-23.7%) |
| Jun 2004 | - | $8.70M(+6.2%) |
| Mar 2004 | - | $8.19M(+113.1%) |
| Dec 2003 | $3.84M(+43.8%) | $3.84M |
| Dec 2002 | $2.67M | - |
FAQ
- What is Alnylam Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual current liabilities year-on-year change?
- What is Alnylam Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly current liabilities year-on-year change?
What is Alnylam Pharmaceuticals annual total current liabilities?
The current annual current liabilities of ALNY is $1.19B
What is the all time high annual current liabilities for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual total current liabilities is $1.19B
What is Alnylam Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, ALNY annual total current liabilities has changed by +$218.49M (+22.58%)
What is Alnylam Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of ALNY is $1.08B
What is the all time high quarterly current liabilities for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly total current liabilities is $1.22B
What is Alnylam Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, ALNY quarterly total current liabilities has changed by +$133.91M (+14.22%)